Matches in SemOpenAlex for { <https://semopenalex.org/work/W41806437> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W41806437 endingPage "54" @default.
- W41806437 startingPage "349" @default.
- W41806437 abstract "Twelve patients with refractory acute leukemia (7 patients with acute myelocytic leukemia and 5 patients with acute lymphocytic leukemia) were treated with a new anthracycline antibiotic, aclacinomycin-A (ACM). ACM was administrated by intravenous drip infusion at a dose of 20 mg/day for 7 or 14 days and this was repeated after at least 7 days. Four of 12 patients (33.3%) achieved a complete remission; 3 of 7 acute myelocytic leukemia (42.8%) and 1 of 5 acute lymphocytic leukemia (20.0%). The days required for achieving the complete remission ranged from 23 to 78 days (median: 61) and the total doses of ACM used from 180 to 500 mg (median: 310), and the durations of complete remission from 11 to 28+ weeks (median: 21+). The untoward effects on digestive organs, such as nausea, vomiting and anorexia, and hematological toxicities were frequently seen; however, they were controlled by supportive treatment. Alopecia was not observed. Arrythmia was recognized in one patient at the initiation of ACM infusion with complete remission without withdrawal of ACM. These results suggest that ACM is a potentially effective anthracycline antibiotic in the clinical management of acute leukemia." @default.
- W41806437 created "2016-06-24" @default.
- W41806437 creator A5001129225 @default.
- W41806437 creator A5014292954 @default.
- W41806437 creator A5025936932 @default.
- W41806437 creator A5029294410 @default.
- W41806437 creator A5037335657 @default.
- W41806437 creator A5043837890 @default.
- W41806437 creator A5050999774 @default.
- W41806437 creator A5060097603 @default.
- W41806437 creator A5066744346 @default.
- W41806437 creator A5069997097 @default.
- W41806437 creator A5071748350 @default.
- W41806437 creator A5090109328 @default.
- W41806437 date "1980-11-01" @default.
- W41806437 modified "2023-09-23" @default.
- W41806437 title "Treatment of refractory acute leukemia with aclacinomycin-A." @default.
- W41806437 doi "https://doi.org/10.18926/amo/30544" @default.
- W41806437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6449134" @default.
- W41806437 hasPublicationYear "1980" @default.
- W41806437 type Work @default.
- W41806437 sameAs 41806437 @default.
- W41806437 citedByCount "3" @default.
- W41806437 crossrefType "journal-article" @default.
- W41806437 hasAuthorship W41806437A5001129225 @default.
- W41806437 hasAuthorship W41806437A5014292954 @default.
- W41806437 hasAuthorship W41806437A5025936932 @default.
- W41806437 hasAuthorship W41806437A5029294410 @default.
- W41806437 hasAuthorship W41806437A5037335657 @default.
- W41806437 hasAuthorship W41806437A5043837890 @default.
- W41806437 hasAuthorship W41806437A5050999774 @default.
- W41806437 hasAuthorship W41806437A5060097603 @default.
- W41806437 hasAuthorship W41806437A5066744346 @default.
- W41806437 hasAuthorship W41806437A5069997097 @default.
- W41806437 hasAuthorship W41806437A5071748350 @default.
- W41806437 hasAuthorship W41806437A5090109328 @default.
- W41806437 hasConcept C121332964 @default.
- W41806437 hasConcept C121608353 @default.
- W41806437 hasConcept C126322002 @default.
- W41806437 hasConcept C141071460 @default.
- W41806437 hasConcept C142424586 @default.
- W41806437 hasConcept C2776694085 @default.
- W41806437 hasConcept C2776802502 @default.
- W41806437 hasConcept C2776863199 @default.
- W41806437 hasConcept C2778461978 @default.
- W41806437 hasConcept C2778654693 @default.
- W41806437 hasConcept C2780580376 @default.
- W41806437 hasConcept C2780852908 @default.
- W41806437 hasConcept C3018657049 @default.
- W41806437 hasConcept C42219234 @default.
- W41806437 hasConcept C530470458 @default.
- W41806437 hasConcept C71924100 @default.
- W41806437 hasConcept C87355193 @default.
- W41806437 hasConcept C90924648 @default.
- W41806437 hasConceptScore W41806437C121332964 @default.
- W41806437 hasConceptScore W41806437C121608353 @default.
- W41806437 hasConceptScore W41806437C126322002 @default.
- W41806437 hasConceptScore W41806437C141071460 @default.
- W41806437 hasConceptScore W41806437C142424586 @default.
- W41806437 hasConceptScore W41806437C2776694085 @default.
- W41806437 hasConceptScore W41806437C2776802502 @default.
- W41806437 hasConceptScore W41806437C2776863199 @default.
- W41806437 hasConceptScore W41806437C2778461978 @default.
- W41806437 hasConceptScore W41806437C2778654693 @default.
- W41806437 hasConceptScore W41806437C2780580376 @default.
- W41806437 hasConceptScore W41806437C2780852908 @default.
- W41806437 hasConceptScore W41806437C3018657049 @default.
- W41806437 hasConceptScore W41806437C42219234 @default.
- W41806437 hasConceptScore W41806437C530470458 @default.
- W41806437 hasConceptScore W41806437C71924100 @default.
- W41806437 hasConceptScore W41806437C87355193 @default.
- W41806437 hasConceptScore W41806437C90924648 @default.
- W41806437 hasIssue "5" @default.
- W41806437 hasLocation W418064371 @default.
- W41806437 hasOpenAccess W41806437 @default.
- W41806437 hasPrimaryLocation W418064371 @default.
- W41806437 hasRelatedWork W1978668887 @default.
- W41806437 hasRelatedWork W1994229131 @default.
- W41806437 hasRelatedWork W2061160794 @default.
- W41806437 hasRelatedWork W2370935967 @default.
- W41806437 hasRelatedWork W2399169835 @default.
- W41806437 hasRelatedWork W2399260822 @default.
- W41806437 hasRelatedWork W2417067678 @default.
- W41806437 hasRelatedWork W41806437 @default.
- W41806437 hasRelatedWork W54063684 @default.
- W41806437 hasRelatedWork W54826626 @default.
- W41806437 hasVolume "34" @default.
- W41806437 isParatext "false" @default.
- W41806437 isRetracted "false" @default.
- W41806437 magId "41806437" @default.
- W41806437 workType "article" @default.